Showing posts with label John LaMattina. Show all posts
Showing posts with label John LaMattina. Show all posts

Thursday, September 13, 2012

Forbes Article Poses Questions Is the FDA Approving Drugs Too Quickly?


There is an interesting article, Is the FDA Approving Drugs Too Quickly? (9/12/12) in Forbes written by John LaMattinaFormer president of Pfizer R&D/senior partner at PureTech Venture.  To read the article click here